UnitedHealth price target raised to $584 from $549 at Mizuho

Mizuho raised the firm’s price target on UnitedHealth to $584 from $549 and keeps a Buy rating on the shares post the Q3 report. Although UnitedHealth did not provide detailed 2024 guidance, the company noted that consensus estimates are towards the high-end of the expected initial range, the analyst tells investors in a research note. The firm views the initial guidance as conservative and believes UnitedHealth will report earnings in-line with the company’s 13%-16% long-term guidance.